Kelly Financial Services LLC Novartis Ag Transaction History

Kelly Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $4,350 - $5,046	47 Added 3.34%	1,455 $154,000
Q1 2023 Jul 17, 2024	BUY	$80.03 - $92.81 $2,961 - $3,433	37 Added 2.7%	1,408 $130 Million
Q3 2022 Jul 17, 2024	SELL	$74.61 - $87.26 $1,865 - $2,181	-25 Reduced 1.79%	1,371 $104 Million
Q1 2022 Jul 17, 2024	BUY	$80.11 - $90.62 $2,643 - $2,990	33 Added 2.42%	1,396 $123 Million
Q4 2021 Jul 17, 2024	SELL	$79.7 - $88.13 $1,753 - $1,938	-22 Reduced 1.59%	1,363 $119 Million
Q3 2021 Jul 17, 2024	SELL	$81.78 - $95.14 $10.2 Million - $11.9 Million	-124,949 Reduced 98.9%	1,385 $113 Million
Q2 2021 Jul 17, 2024	BUY	$85.24 - $94.15 $10.7 Million - $11.8 Million	124,949 Added 9021.59%	126,334 $1.39 Million
Q1 2021 Jul 17, 2024	BUY	$83.5 - $98.47 $111,723 - $131,752	1,338 Added 2846.81%	1,385 $118 Million
Q3 2019 Jul 17, 2024	BUY	$85.54 - $94.26 $4,020 - $4,430	47 New	47 $4.08 Million

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $228B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.